Literature DB >> 35285278

Continuing Increase in Stimulant Dependence - Time to Implement Medical Treatment.

Adam Bisaga1, Vitor S Tardelli2,3, Gilberto Gerra4, Anja Busse5, Giovanna Campello5, Wataru Kashino5, Elizabeth Saenz5, Thiago M Fidalgo2,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35285278      PMCID： PMC9234894          DOI： 10.1177/07067437221083505

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   5.321


× No keyword cloud information.
  25 in total

1.  The ethics of global clinical trials: In developing countries, participation in clinical trials is sometimes the only way to access medical treatment. What should be done to avoid exploitation of disadvantaged populations?

Authors:  Katrin Weigmann
Journal:  EMBO Rep       Date:  2015-04-07       Impact factor: 8.807

Review 2.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

3.  Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.

Authors:  Einat Peles; Shaul Schreiber; Anat Sason; Miriam Adelson
Journal:  J Addict Med       Date:  2011-06       Impact factor: 3.702

4.  The profile of psychiatric symptoms exacerbated by methamphetamine use.

Authors:  Rebecca McKetin; Sharon Dawe; Richard A Burns; Leanne Hides; David J Kavanagh; Maree Teesson; Ross McD Young; Alexandra Voce; John B Saunders
Journal:  Drug Alcohol Depend       Date:  2016-01-30       Impact factor: 4.492

5.  A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.

Authors:  Joy M Schmitz; Charles E Green; Angela L Stotts; Jan A Lindsay; Nuvan S Rathnayaka; John Grabowski; F Gerard Moeller
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

Review 6.  Psychostimulant drugs for cocaine dependence.

Authors:  Xavier Castells; Ruth Cunill; Clara Pérez-Mañá; Xavier Vidal; Dolors Capellà
Journal:  Cochrane Database Syst Rev       Date:  2016-09-27

7.  Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.

Authors:  Nadine Ezard; Brendan Clifford; Adrian Dunlop; Raimondo Bruno; Andrew Carr; Zhixin Liu; Krista J Siefried; Nicholas Lintzeris
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

8.  Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Jaclyn Hern; Eric Vittinghoff; John E Walker; Tim Matheson; Deirdre Santos; Grant Colfax; Steven L Batki
Journal:  JAMA Psychiatry       Date:  2020-03-01       Impact factor: 21.596

9.  LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.

Authors:  Nadine Ezard; Adrian Dunlop; Michelle Hall; Robert Ali; Rebecca McKetin; Raimondo Bruno; Nghi Phung; Andrew Carr; Jason White; Brendan Clifford; Zhixin Liu; Marian Shanahan; Kate Dolan; Amanda L Baker; Nicholas Lintzeris
Journal:  BMJ Open       Date:  2018-07-19       Impact factor: 2.692

10.  Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.

Authors:  Krista J Siefried; Liam S Acheson; Nicholas Lintzeris; Nadine Ezard
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.